5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3324/haematol.2019.224030
PubMed Identifier: 31488558
Publication URI: http://europepmc.org/abstract/MED/31488558
Type: Journal Article/Review
Volume: 105
Parent Publication: Haematologica
Issue: 5
ISSN: 0390-6078